The primary goal of the Annual Meeting is to provide a stimulating and lively forum for presentation and discussion of the latest advances in clinical immunology, including primary immunodeficiencies and immune dysregulatory diseases, and related areas, including molecular pathogenesis, and novel therapeutic approaches.